Pharmaceutical Technology
JULY 18, 2022
GlaxoSmithKline (GSK) has signed an agreement with the Government of Canada for pandemic and seasonal influenza vaccines to aid in protecting adults and children in the country. The company intends to supply both vaccines from its 230,000ft² Sainte-Foy facility in Quebec. .
Pharmacy Is Right For Me
OCTOBER 21, 2022
I worked in Dallas from 95-2001, then moved to NYC, then years later went to the University of Colorado for the NTPD program and received the PharmD. When the monkeypox outbreak was happening here in NYC, I used my platform to be a source of information about vaccines and TPOXX treatments. What led you to this career path?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MARCH 9, 2021
SARS-CoV-2 is likely to stay endemic in the human population for the foreseeable future, ExeVir noted, with variants capable of evading immunity the most likely cause of the disease in the future as global vaccination programmes begin to take effect. ExeVir is not the first company to spin out of VIB to focus on camelid antibodies.
The People's Pharmacy
JUNE 1, 2023
Discovered in 2001, HMPV is in the Pneumoviridae family along with respiratory syncytial virus (RSV).” ” What jumps out for me is that this virus was only “discovered” in 2001 by Dutch researchers. There are no easy tests for HMPV, no vaccinations and no treatments.
The People's Pharmacy
MAY 10, 2023
Studying Dog Owners: The study was conducted in Sweden between 2001 and 2012 and included more than 300,000 individuals who had experienced a stroke or a heart attack ( Circulation: Cardiovascular Quality and Outcomes , Oct. There are vaccines for canine influenza. Dogs can spread the virus between each other with close contact.
pharmaphorum
NOVEMBER 23, 2020
He joined Johnson & Johnson in 2001 as Director Corporate Communications. Later, he built the external relationships in the field of Hepatitis C, before becoming the Global Therapeutic Area Communications Leader Infectious Diseases and Vaccines. About the author. In that function, he initially worked in the field of oncology.
pharmaphorum
SEPTEMBER 18, 2020
Between 2001 and 2005, Nexium netted AstraZeneca approximately $14.4 In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 The AZD1222 vaccine was invented by the University of Oxford and its spin-out company Vaccitech, then later licensed by AZ.
Expert insights. Personalized for you.
64 
Let's personalize your content